Urinary Incontinence clinical trials

Explore recruiting urinary incontinence clinical trials.

Recruiting urinary incontinence studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Urinary Incontinence trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of treatment effectiveness and safety of somatic cell based therapy for urinary incontinence in patients after radical prostatectomy, multicenter randomized, double-blind, placebo controlled, clinical trial.

Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Evaluation of safety of somatic cell based therapy for urinary incontinence in patients after radical prostatectomy, open trial.

Poland

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

EFFICACY AND SAFETY OF CROMOGLYCATE AS A NEW SYMPTOMATIC TREATMENT IN PATIENTS WITH MULTIPLE SCLEROSIS

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

J2A-MC-GZPS: A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared with Placebo in Female Participants with Stress Urinary Incontinence Who Have Obesity or Overweight (RESTRAIN-SUI) ; J2A-MC-GZS1: A Study to Investigate Efficacy and Safety of Orforglipron Once Daily in Participants with Stress Urinary Incontinence Who Have Obesity or Overweight ; J2A-MC-GZS2: A Study to Investigate Efficacy and Safety of Orforglipron Once Daily in Participants with Stress Urinary Incontinence Who Have Obesity or Overweight

Romania, Czechia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effective strategy of withdrawal of pharmacological treatment of urinary incontinence in children (StayDry)

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy of intravesical oxybutynin in children with neurogenic bladder dysfunction: A randomized, prospective controlled multi-center trial.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Urinary Incontinence trials by city

Urinary Incontinence in Toronto Urinary Incontinence in Vancouver Urinary Incontinence in Montreal Urinary Incontinence in Calgary Urinary Incontinence in Edmonton Urinary Incontinence in Ottawa Urinary Incontinence in Winnipeg Urinary Incontinence in Quebec City Urinary Incontinence in Hamilton Urinary Incontinence in Kitchener Urinary Incontinence in London Urinary Incontinence in Halifax Urinary Incontinence in New York Urinary Incontinence in Los Angeles Urinary Incontinence in Chicago Urinary Incontinence in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease